Facility Design Webinars
-
Get To Know WuXi Advanced Therapies Testing Services
3/21/2024
Learn how we can help you move your pipeline forward, whether you manufacture with us at WuXi Advanced Therapies, in-house, or with one of our fellow CDMOs.
-
Single-Use Microbial Impactor On A Filling Line
3/6/2024
Discover the advantages of a single-use microbial impactor through a demonstration of its ease of use in an isolator and an explanation of its ability to eliminate false positives.
-
How Airflow Visualization Characterizes Pharmaceutical Sterility
2/22/2024
Explore how airflow visualization studies influence contamination control and risk management in pharmaceutical environments.
-
Understanding ISO/TR 14644-21 Airborne Particle Sampling Techniques
2/22/2024
Industry expert Mark Hallworth guides viewers through the latest ISO document (ISO 14644), exploring the reasons behind the decisions made by the team during its development.
-
Multimodal R&D Management With Incyte's Jim Lee, M.D., Ph.D.
1/18/2024
Success at multimodal, multi-indication, deep-pipelined Incyte—where commercial operations are as familiar as pre-discovery activity is—begins at the earliest opportunity to achieve research and discovery efficiencies.
-
The Closed Processing Advantage: Optimizing Biopharma Facilities
11/16/2023
Explore the evolving landscape of biopharma facility design and operations, including key market trends, closed processing benefits, and industry efforts to harmonize guidance and best practices.
-
Continuous Growth In Advanced Therapies
8/15/2023
As the industry continues to see innovation in manufacturing approaches, the Project Farma team discusses how advanced therapies differ from traditional medicines.
-
Modular Cleanroom Overview
7/14/2023
Gain insight into AES' projects and experience in cleanroom design innovation, manufacturing, and construction. In this overview, Avid Bioservices, INCOG BioPharma, Theragent, and Charles River share the value of partnering with AES.
-
Audience Q&A
6/7/2023
Listen in to real-time questions and answers from the audience. During “Building An In-House Cell & Gene Manufacturing Facility – Best Practices & Lessons Learned.”
-
Speed To Clinic
6/7/2023
Does or should speed to clinic impact a company’s decision to build versus buy? Explore this question and others along with lessons regarding capacity and meeting anticipated demand.